Weight Loss at Curate
Weight loss, clinically curated.
Weight is shaped by your biology, health history and lifestyle — not willpower alone. A Curate clinician assesses your whole health picture and, where clinically appropriate, builds a course of care around it, with reviews at every stage.
- UK-registered clinicians
- GPhC-registered pharmacy
- CQC-regulated service
Choose your pathway
Curated for her, and for him.
The same standard of clinical care, tailored to how weight works differently for women and men.
Eligibility
Is treatment suitable for me?
Prescribing weight-loss treatment starts with your body mass index (BMI). This is about safety, not judgement. It gives you an idea whether GLP-1 medication is suitable before taking an online consultation.
Your BMI is a screening estimate for eligibility, not a diagnosis. Once you have completed your online consultation, a clinician will review your health profile. This will determine whether treatment is right for you.
Based on the 21% average body-weight reduction over 72 weeks in tirzepatide trials (Jastreboff et al., NEJM 2022). Individual results vary.
You may be eligible
Treatment can be appropriate at this BMI if you also have a weight-related health condition. A clinician reviews your full picture before deciding.
Start your consultationExplore treatments and guides
Advice & guides
Knowledge that keeps you going.
When to increase your Mounjaro dose (and when not to)
Mounjaro's six-step dose ladder is not a race. How prescribers decide when to move up, why staying at a lower dose can be the right call, and the questions to bring to review.
What is tirzepatide? The dual-action medicine explained
Tirzepatide is the first medicine to activate both GLP-1 and GIP gut-hormone receptors. What it is, how it differs from semaglutide, what the trials show and who it suits.
Does Mounjaro cause hair loss?
Hair shedding on Mounjaro is usually the weight loss talking, not the drug. Why rapid loss triggers shedding, how long it lasts, and what actually helps it recover.
Good to know
Questions, answered honestly.
If anything here doesn't cover it, our care team is one message away.
Still have questions? Message the care team
I'm in perimenopause: is this suitable for me?
Often, yes. Your assessment captures your hormonal stage and history so your clinician can decide what's appropriate and safe for you specifically. If something else would serve you better, they'll say so.
What if I'm pregnant or breastfeeding?
Weight-loss treatment isn't suitable during pregnancy or breastfeeding. Your clinician will talk you through safe options and timing.
How do I know if I'm eligible?
Eligibility is based on your assessment, including measurements, health history and goals. There's no charge to find out, and you're never pressured to proceed.
Can I pause or stop?
Yes, you're in control. You can pause or stop any time from your account, and your clinician will advise on doing so safely.
References
- Jastreboff AM et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387:205-21. nejm.org
- Mounjaro (tirzepatide) Summary of Product Characteristics. medicines.org.uk/emc/product/15484/smpc
- Wegovy (semaglutide) Summary of Product Characteristics. medicines.org.uk/emc/product/13799/smpc